DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

10,300

Employees10,300

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

10,300

Employees10,300

DXCM Key Statistics

Market cap

25.56B

Market cap25.56B

Price-Earnings ratio

45.59

Price-Earnings ratio45.59

Dividend yield

—

Dividend yield—

Average volume

4.66M

Average volume4.66M

High today

$66.37

High today$66.37

Low today

$64.75

Low today$64.75

Open price

$65.99

Open price$65.99

Volume

3.38M

Volume3.38M

52 Week high

$93.25

52 Week high$93.25

52 Week low

$57.52

52 Week low$57.52

DXCM News

Barchart 11h

DexCom Earnings Preview: What to Expect

Valued at a market cap of $25.5 billion , DexCom, Inc. ( DXCM ) is a medical device company that designs, develops, and commercializes continuous glucose monito...

Simply Wall St 2d

Should You Reconsider DexCom After Shares Fall 14% in April 2025?

Trying to decide whether DexCom belongs in your portfolio right now? You are definitely not alone. The company is a household name in continuous glucose monitor...

TipRanks 7d

DexCom price target lowered to $85 from $105 at Citi

Citi lowered the firm’s price target on DexCom (DXCM) to $85 from $105 and keeps a Buy rating on the shares. The firm is cautious on medical technology entering...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.